期刊
JOURNAL OF DIABETES
卷 14, 期 6, 页码 377-393出版社
WILEY
DOI: 10.1111/1753-0407.13288
关键词
cardiometabolic disease; circadian rhythms; gut microbiome; intermittent fasting; time-restricted feeding
资金
- Nehemia Levtzion Scholarship for Outstanding Doctoral Students
- Ariane de Rothschild Women Doctoral Program
- Leona M. and Harry B. Helmsley Charitable Trust
- Adelis Foundation
- Ben B. and Joyce E. Eisenberg Foundation
- Estate of Bernard Bishin for the WIS-Clalit Program
- Jeanne and Joseph Nissim Center for Life Sciences Research
- Miel de Botton
- Swiss Society Institute for Cancer Prevention Research
- Belle S. and Irving E. Meller Center for the Biology of Aging
- Sagol Institute for Longevity Research
- Sagol Weizmann-MIT Bridge Program
- Norman E Alexander Family M Foundation Coronavirus Research Fund
- Mike and Valeria Rosenbloom Foundation
- Daniel Morris Trust
- Isidore and Penny Myers Foundation
- Vainboim Family
- European Research Council
- Israel Science Foundation
- Israel Ministry of Science and Technology
- Israel Ministry of Health
- German-Israeli Helmholtz International Research School
- Cancer-TRAX [HIRS-0003]
- Helmholtz Association's Initiative and Networking Fund
- Minerva Foundation
- Garvan Institute
- European Crohn's and Colitis Organization
- Deutsch-Israelische Projektkooperation
- IDSA Foundation
- WIS-MIT grant
- Emulate
- Charlie Teo Foundation
- Mark Foundation for Cancer Research
- Welcome Trust
- Vera Rosenberg Schwartz Research Fellow Chair
Intermittent fasting is considered a promising treatment for cardiometabolic diseases and has positive effects on the gut microbiome and the host circadian clock. This review discusses the relationship between gut microbiome alterations and intermittent fasting's impact on mammalian metabolism and cardiovascular diseases, highlighting the challenges of linking bacterial signals with dietary cues and incorporating microbiome into precision medicine.
In recent years, intermittent fasting (IF), including periodic fasting and time-restricted feeding (TRF), has been increasingly suggested to constitute a promising treatment for cardiometabolic diseases (CMD). A deliberate daily pause in food consumption influences the gut microbiome and the host circadian clock, resulting in improved cardiometabolic health. Understanding the molecular mechanisms by which circadian host-microbiome interactions affect host metabolism and immunity may add a potentially important dimension to effective implementation of IF diets. In this review, we discuss emerging evidence potentially linking compositional and functional alterations of the gut microbiome with IF impacts on mammalian metabolism and risk of development of hypertension, type 2 diabetes (T2D), obesity, and their long-term micro- and macrovascular complications. We highlight the challenges and unknowns in causally linking diurnal bacterial signals with dietary cues and downstream metabolic consequences and means of harnessing these signals toward future microbiome integration into precision medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据